Medy-Tox Inc. (KOSDAQ:086900)

Kronos Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	51,927	46,168	33,246	20,688	71,777	43,993
Short-Term Investments	2,563	6,112	98.91	3,000	10,150	11,621
Trading Asset Securities	-	7,235	-	2,520	-	-
Cash & Short-Term Investments	54,490	59,515	33,345	26,208	81,927	55,614
Cash Growth	48.61%	78.48%	27.23%	-68.01%	47.31%	136.49%
Accounts Receivable	51,983	53,880	60,508	44,998	28,703	34,165
Other Receivables	4,516	2,889	6,139	6,485	12,057	5,224
Receivables	56,499	56,817	67,502	53,302	43,523	42,165
Inventory	58,964	64,259	59,618	52,620	32,971	37,555
Prepaid Expenses	-	1,392	2,892	1,866	966.57	1,630
Other Current Assets	5,933	4,585	2,875	1,138	1,571	1,747
Total Current Assets	175,885	186,568	166,232	135,134	160,959	138,711
Property, Plant & Equipment	198,441	200,270	205,262	208,878	205,531	214,007
Long-Term Investments	74,486	75,703	113,576	155,410	122,377	24,081
Goodwill	8,136	8,136	-	-	808.49	-
Other Intangible Assets	5,505	6,663	4,730	4,412	4,689	14,060
Long-Term Deferred Tax Assets	25,504	24,372	17,973	14,267	18,187	21,238
Long-Term Deferred Charges	60,274	57,230	49,490	22,058	6,308	3,893
Other Long-Term Assets	53,769	54,974	53,000	55,324	58,766	51,638
Total Assets	603,179	615,163	611,623	596,288	577,698	467,764
Accounts Payable	1,102	3,116	3,749	3,390	4,028	3,994
Accrued Expenses	2,523	5,229	7,118	9,389	1,554	1,971
Short-Term Debt	54,620	59,306	61,079	95,103	64,964	81,279
Current Portion of Long-Term Debt	500	-	20,000	5,012	12,000	-
Current Portion of Leases	718.94	731.95	525.21	411.35	571.91	558.87
Current Income Taxes Payable	3,369	4,872	7,982	7,993	13,861	1.13
Current Unearned Revenue	15.76	-	-	-	361.68	361.68
Other Current Liabilities	49,339	38,433	26,103	13,964	10,606	29,424
Total Current Liabilities	112,188	111,688	126,556	135,262	107,947	117,590
Long-Term Debt	19,500	20,000	-	20,000	55,057	65,263
Long-Term Leases	1,279	1,279	1,226	335.95	324.74	309.67
Long-Term Unearned Revenue	-	-	-	-	1,296	1,658
Long-Term Deferred Tax Liabilities	255.86	308.87	229.31	818.57	505.65	943.57
Other Long-Term Liabilities	5,065	5,036	8,998	6,256	8,062	34,809
Total Liabilities	138,525	138,513	137,141	162,673	174,134	222,962
Common Stock	3,649	3,649	3,649	3,331	3,127	2,989
Additional Paid-In Capital	148,053	148,053	148,037	112,896	113,978	48,688
Retained Earnings	432,500	425,211	406,665	401,111	364,112	268,147
Treasury Stock	-117,034	-106,887	-96,921	-106,229	-89,296	-81,171
Comprehensive Income & Other	-5,779	-3,770	7,813	16,693	7,288	2,676
Total Common Equity	461,388	466,256	469,242	427,802	399,208	241,328
Minority Interest	3,045	4,309	5,020	5,571	4,084	3,405
Shareholders' Equity	464,654	476,649	474,482	433,616	403,565	244,802
Total Liabilities & Equity	603,179	615,163	611,623	596,288	577,698	467,764
Total Debt	76,618	81,318	82,830	120,862	132,917	147,410
Net Cash (Debt)	-22,127	-21,803	-49,485	-94,654	-50,990	-91,796
Net Cash Per Share	-2786.89	-3242.53	-7389.19	-14418.99	-7944.34	-14307.35
Filing Date Shares Outstanding	7.02	6.66	6.73	6.04	6.06	6.11
Total Common Shares Outstanding	7.02	6.66	6.73	6.34	6.36	6.41
Working Capital	63,697	74,880	39,676	-128.34	53,012	21,121
Book Value Per Share	65730.60	70014.36	69721.64	67506.12	62787.02	37638.40
Tangible Book Value	447,748	451,457	464,512	423,390	393,711	227,268
Tangible Book Value Per Share	63787.30	67792.17	69018.83	66809.98	61922.46	35445.54
Land	49,514	49,514	49,514	49,514	46,032	50,466
Buildings	74,953	94,198	94,122	74,039	73,053	73,723
Machinery	5,322	29,687	28,021	26,103	24,476	22,737
Construction In Progress	14,501	13,605	14,218	71,941	64,047	56,978

Source: S&P Global Market Intelligence. Standard template. Financial Sources.